Talis Biomedical Correlations
The current 90-days correlation between Talis Biomedical Corp and Nuwellis is 0.02 (i.e., Significant diversification). The correlation of Talis Biomedical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Talis |
The ability to find closely correlated positions to Talis Biomedical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Talis Biomedical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Talis Biomedical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Talis Biomedical Corp to buy it.
Moving together with Talis Pink Sheet
| 0.77 | DYNT | Dynatronics Earnings Call This Week | PairCorr |
| 0.69 | XAIR | Beyond Air | PairCorr |
| 0.7 | BVS | Bioventus | PairCorr |
| 0.61 | VMD | Viemed Healthcare | PairCorr |
| 0.78 | WOK | WORK Medical Technology | PairCorr |
Moving against Talis Pink Sheet
| 0.82 | BBLGW | Bone Biologics Corp Trending | PairCorr |
| 0.8 | BSX | Boston Scientific Corp | PairCorr |
| 0.74 | ELMD | Electromed | PairCorr |
| 0.72 | ECOR | Electrocore LLC | PairCorr |
| 0.71 | DXCM | DexCom Inc Earnings Call This Week | PairCorr |
| 0.67 | PEN | Penumbra | PairCorr |
| 0.59 | FNA | Paragon 28 | PairCorr |
| 0.56 | MYO | Myomo Inc | PairCorr |
| 0.53 | VVOS | Vivos Therapeutics | PairCorr |
| 0.38 | ABT | Abbott Laboratories | PairCorr |
| 0.83 | GKOS | Glaukos Corp | PairCorr |
| 0.79 | XYLO | Xylo Technologies Symbol Change | PairCorr |
| 0.79 | IRTC | iRhythm Technologies | PairCorr |
| 0.77 | ICCM | Icecure Medical | PairCorr |
| 0.77 | IRMD | Iradimed Earnings Call This Week | PairCorr |
| 0.71 | GMED | Globus Medical | PairCorr |
| 0.66 | BDMDW | Baird Medical Investment | PairCorr |
| 0.66 | ICAD | icad inc Trending | PairCorr |
| 0.6 | INGN | Inogen Inc | PairCorr |
| 0.48 | XTNT | Xtant Medical Holdings | PairCorr |
| 0.45 | HSDT | Helius Medical Techn | PairCorr |
| 0.39 | ITGR | Integer Holdings Corp | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Talis Pink Sheet performing well and Talis Biomedical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Talis Biomedical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| TIVC | 6.61 | 0.31 | 0.03 | (0.74) | 6.40 | 12.12 | 82.47 | |||
| BJDX | 9.37 | 0.24 | 0.06 | 0.12 | 11.45 | 19.21 | 120.57 | |||
| HSCS | 3.49 | 0.19 | 0.02 | (0.49) | 3.86 | 7.12 | 39.74 | |||
| NUWE | 7.56 | 0.42 | 0.04 | 0.48 | 9.80 | 13.26 | 141.14 | |||
| BBLG | 3.71 | (0.69) | 0.00 | (1.44) | 0.00 | 8.91 | 21.45 | |||
| INVO | 5.41 | 0.60 | 0.09 | (1.32) | 4.82 | 8.96 | 105.62 | |||
| TNON | 3.21 | (1.17) | 0.00 | (2.13) | 0.00 | 5.33 | 35.40 | |||
| MOTS | 3.80 | (0.23) | 0.00 | (1.11) | 0.00 | 9.09 | 56.89 | |||
| BVS | 2.38 | (0.22) | 0.00 | 0.36 | 0.00 | 5.25 | 18.29 | |||
| SGHT | 2.80 | (0.76) | 0.00 | 2.74 | 0.00 | 6.65 | 17.90 |
Talis Biomedical Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Talis Biomedical pink sheet to make a market-neutral strategy. Peer analysis of Talis Biomedical could also be used in its relative valuation, which is a method of valuing Talis Biomedical by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Talis Biomedical Corporate Management
| Roger Moody | Chief Officer | Profile | |
| Gillian Green | Company Secretary | Profile | |
| Margaret MS | Controller | Profile | |
| Rustem Ismagilov | CoFounder Director | Profile | |
| Rebecca Markovich | Interim Officer | Profile | |
| Jill Green | Senior Legal | Profile |
Still Interested in Talis Biomedical Corp?
Investing in delisted pink sheets can be risky, as the pink sheet is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.